Pathofinder

Pathofinder

Next Generation Multiplex PCR Diagnostics.
  • Edit
DateInvestorsAmountRound

€50.0k

Grant

€390k

Grant
Total FundingCAD660k

Recent News about Pathofinder

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Pathofinder

Edit
Naurex
ACQUISITION by Allergan Jul 2015